We can, therefore, only assume that these genetic aberrations predispose lymphoma cells to the initiation and perpetuation of NLRP3 inflammasome signaling via either structural differences or the quantitative increase in its related protein components. This evidence concerns the gene NLRP3 and lymphoma.